Browse Category

NASDAQ:SCNX News 23 October 2025 - 24 October 2025

Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next?

Scienture’s unprecedented Oct. 23 rally was driven by the commercial rollout of Arbli, its first revenue-generating product. The company’s press release on Oct. 23 confirmed that it began sales and shipped first customer orders for Arbli (losartan suspension), immediately triggering the Nasdaq surgefinviz.com. CEO/co-CEO Narasimhan Mani said the event “represents a major achievement for Scienture” in moving from development to executionfinviz.com. Investors piled in on the news: as Benzinga reported, SCNX shares leapt over 140% on Thursday following word of the launchbenzinga.combenzinga.com. The price pop was staggering for a penny stock. Finviz confirmed the stock hit $2.60 on Oct. 23,
24 October 2025
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

SCNX Stock Soars on Arbli Launch News Scienture’s stock has been on a rollercoaster in late October amid excitement over Arbli’s rollout. The initial catalyst came on October 16, 2025, when the company announced Arbli™ was available through major wholesalers – making it the first FDA-approved liquid losartan on the market ts2.tech. That morning, SCNX shares surged over 30% from the prior day’s $0.72 close, even hitting an intraday high around $1.12 before profit-taking set in ts2.tech. By mid-day Oct. 16, Reuters reported the stock had pulled back near $0.71 ts2.tech, indicating traders sold into the early pop. Still, the

Stock Market Today

Adobe stock (ADBE) slips into the weekend — what traders watch before Monday

Adobe stock (ADBE) slips into the weekend — what traders watch before Monday

8 February 2026
Adobe shares closed down 0.4% at $268.38 Friday, trailing a broader tech rally that sent the Dow above 50,000 for the first time. Semrush shareholders approved a merger with Adobe, advancing the $1.9 billion deal. Investors await key U.S. jobs and inflation data this week. Adobe’s next earnings report is expected in mid-March.
Snowflake stock snaps back with 7% jump — what to watch before Monday

Snowflake stock snaps back with 7% jump — what to watch before Monday

8 February 2026
Snowflake shares jumped 7.5% to $168.43 Friday, tracking a late-week tech rebound. Director Michael L. Speiser sold 50,741 shares on Feb. 6 under a pre-set plan, according to a regulatory filing. The company recently announced a $200 million partnership with OpenAI. Snowflake reports earnings Feb. 25.
Go toTop